Viewing StudyNCT00294164



Ignite Creation Date: 2024-05-05 @ 4:43 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00294164
Status: COMPLETED
Last Update Posted: 2014-03-26
First Post: 2006-02-16

Brief Title: Safety and Efficacy Trial of Serostim in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome HARS
Sponsor: EMD Serono
Organization: EMD Serono

Conditions & Keywords Data

Conditions:
Name
Human Immunodeficiency Virus Infections
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome HARS
Keywords:
Name View
Placebo View
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome HARS View
Human Immunodeficiency Virus Infections View
recombinant human growth hormone r-hGH View
Serostim View